NSN 6505-01-254-9596 (6505012549596) Datasheet

At NSN Unlimited, we maintain a large database of parts NDC00023-0773-50 with NSN 6505-01-254-9596 used in civil and defense applications for the aerospace, marine, and commercial manufactured by Allergan Ltd. Utilize our interface to browse items by part number, part type, manufacturer, and more. Obtain insights on top MRO and FBO services, Manufacturer profiles, and part catalogs.

With an unmatched supply-chain network, we are able to provide expedited shipping and same-day or next-day delivery on qualifying parts.

Ready for a quote? Submit an Instant RFQ today for NSN 6505-01-254-9596

Alternative NSN: 6505-01-254-9596
Item Name: Griseofulvin Tablet
NIIN: 012549596
NCB Code: USA (01)
Manufacturers: Allergan Ltd

Cross Reference | NSN 6505012549596

Part No NSN Item Name Manufacturer QTY RFQ
NDC00023-0773-50 6505-01-254-9596 griseofulvin tablet allergan ltd Avl RFQ

Technical Data | NSN 6505012549596

MRCCriteriaCharacteristic
AJUCAMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER081204
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
CQCTPRIMARY CONTAINER TYPEBOTTLE
CRLKPRIMARY CONTAINER CONTENT QUANTITY500.000 TABLETS
CSGSADMINISTRATIONORAL
MDESMEDICAL DESIGNATIONUNITED STATES PHARMACOPEIA

People also Searched for these Related NSN 6505012549596

Get Instant Quote

Guaranteed quotes back within 15 minutes, 24/7 x 365

Low Price Warrantied inventory at competitive prices
Find it fast Search the world's largest inventory of electronic components by manufacturer, category or part number
Get it fast All inventory ready to ship from our sellers
Quality guaranteed We sell only warrantied and traceable parts

 Semiconductor's Certifications and Memberships

Thank You for Visiting NSN Unlimited.

If You’d Like to Stay Up to Date On Our Latest, Up-To-Date NSN Parts; Kindly Explore Our Catalog and Get Quote for Your Required Part Number.

Request for Quote

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.